On April 29, 2019, CTS will begin performing Donor-Screen HLA® Class I and II testing on the Stratec Biomedical AG Gemini. This instrumentation change is necessary as Bio-Rad is discontinuing service on our existing QuickStep instrumentation.
Although the Immucor assay and sample requirements will remain the same, the package insert has been modified to state the assay is specific to the Stratec Gemini instrument. The new package insert, assay history list, and platform history list will be available on the CTS website on 04/29/19.
An exciting enhancement is implementing January 20, 2020 in our Special Testing laboratory as we mov...
CTS will be revising some forms in use by clients on October 26, 2020. We do try to limit form chang...
The recent communication regarding the recent Anti-SARS-CoV-2 Total assay in Tampa has brought about...
We are informing you that the FDA has announced their withdrawal of Guidance for ZIKV Testing. In th...
The new online Learning Center with new content can still be found under the “Training” folder on ...
That’s just one of the reasons that National Blood Donor Month, which has taken place each Jan...